V009-6453 Screening compound: 4-[6-(benzenesulfonyl)-2-[4-(3,4-dimethylphenyl)piperazin-1-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

V009-6453 Screening compound: 4-[6-(benzenesulfonyl)-2-[4-(3,4-dimethylphenyl)piperazin-1-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine
V009-6453 Screening compound: 4-[6-(benzenesulfonyl)-2-[4-(3,4-dimethylphenyl)piperazin-1-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-6453
4-[6-(benzenesulfonyl)-2-[4-(3,4-dimethylphenyl)piperazin-1-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-6453

Molecular Formula

C29H36N6O3S (C29 H36 N6 O3 S)

Compound Name

4-[6-(benzenesulfonyl)-2-[4-(3,4-dimethylphenyl)piperazin-1-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

IUPAC name

4-[6-(benzenesulfonyl)-2-[4-(34-dimethylphenyl)piperazin-1-yl]-5H6H7H8H-pyrido[43-d]pyrimidin-4-yl]morpholine

SMILES

Cc(cc1)c(C)cc1N(CC1)CCN1c1nc(N2CCOCC2)c(CN(CC2)S(c3ccccc3)(=O)=O)c2n1

InChI

InChI=1S/C29H36N6O3S/c1-22-8-9-24(20-23(22)2)32-12-14-34(15-13-32)29-30-27-10-11-35(39(36,37)25-6-4-3-5-7-25)21-26(27)28(31-29)33-16-18-38-19-17-33/h3-9,20H,10-19,21H2,1-2H3

InChI Key

MGZMYNGVFCANHH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908893

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.71

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.175

Distribution Coefficient, logD

5.174

Water Solubility, LogSw

-5.16

Polar Surface Area

68.617

Acid Dissociation Constant (pKa)

20.31

Base Dissociation Constant (pKb)

4.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.80

V009-6453 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-6453 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-6453?
Check Price and Availability of V009-6453, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-6453 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-6453
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-6453
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-6453 available by request